Yantai Dongcheng Biochemicals Co.,Ltd. (002675.SZ) announced that its subsidiary, Yantai Lannacheng Biotechnology Co., Ltd., has received the "Radioactive Drug Production License" issued by the Shandong Provincial Drug Administration. The acquisition of this production license is not expected to have a significant impact on the company's current performance. The commercialization of Fluorine [18F] SiRuitai Injection can proceed upon obtaining the drug marketing approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments